Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Conus

Showing results (241-250 of 289) with videos related to

Pageof 29
Sort By:
Early Intervention in Psychiatry|April 27, 2024
Pathways to care in youth and young adults at clinical high risk for psychosis in Switzerland: Current situation and clinical implementation of the PsyYoung projectBarbara Bailey, Alessandra Solida, Christina Andreou, et al.
International Journal of Methods in Psychiatric Research|August 17, 2022
Mental health service areas in SwitzerlandNiklaus Stulz, Reto Jörg, Constanze Reim-Gautier, et al.
Molecular Psychiatry|October 23, 2021
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophreniaInes Khadimallah, Raoul Jenni, Jan-Harry Cabungcal, et al.
Pharmacogenetics and Genomics|March 10, 2015
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatmentsLina Quteineh, Frederik Vandenberghe, Nuria Saigi Morgui, et al.
Imaging Neuroscience (Cambridge, Mass.)|June 22, 2026
High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosisEdgar Céléreau, Federico Lucchetti, Yasser Alemán-Gómez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 16, 2007
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsSuzie Lavoie, Micah M Murray, Patricia Deppen, et al.
Frontiers in Psychiatry|January 6, 2022
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric CohortNermine Laaboub, Mehdi Gholam, Guibet Sibailly, et al.
The Australian and New Zealand Journal of Psychiatry|August 12, 2009
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristicsLisa J Phillips, Barnaby Nelson, Hok Pan Yuen, et al.
Schizophrenia Bulletin|September 19, 2025
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet InsertGeorgios Schoretsanitis, Nermine Laaboub, Séverine Crettol, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 4, 2017
Quetiapine <i>v.</i> lithium in the maintenance phase following a first episode of mania: randomised controlled trialMichael Berk, Rothanthi Daglas, Orwa Dandash, et al.
Pageof 29

Showing results (241-250 of 289) with videos related to

Sort By:
Pageof 29
Early Intervention in Psychiatry|April 27, 2024
Pathways to care in youth and young adults at clinical high risk for psychosis in Switzerland: Current situation and clinical implementation of the PsyYoung projectBarbara Bailey, Alessandra Solida, Christina Andreou, et al.
International Journal of Methods in Psychiatric Research|August 17, 2022
Mental health service areas in SwitzerlandNiklaus Stulz, Reto Jörg, Constanze Reim-Gautier, et al.
Molecular Psychiatry|October 23, 2021
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophreniaInes Khadimallah, Raoul Jenni, Jan-Harry Cabungcal, et al.
Pharmacogenetics and Genomics|March 10, 2015
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatmentsLina Quteineh, Frederik Vandenberghe, Nuria Saigi Morgui, et al.
Imaging Neuroscience (Cambridge, Mass.)|June 22, 2026
High-resolution whole-brain magnetic resonance spectroscopic imaging in youth at risk for psychosisEdgar Céléreau, Federico Lucchetti, Yasser Alemán-Gómez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 16, 2007
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsSuzie Lavoie, Micah M Murray, Patricia Deppen, et al.
Frontiers in Psychiatry|January 6, 2022
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric CohortNermine Laaboub, Mehdi Gholam, Guibet Sibailly, et al.
The Australian and New Zealand Journal of Psychiatry|August 12, 2009
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristicsLisa J Phillips, Barnaby Nelson, Hok Pan Yuen, et al.
Schizophrenia Bulletin|September 19, 2025
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet InsertGeorgios Schoretsanitis, Nermine Laaboub, Séverine Crettol, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 4, 2017
Quetiapine <i>v.</i> lithium in the maintenance phase following a first episode of mania: randomised controlled trialMichael Berk, Rothanthi Daglas, Orwa Dandash, et al.
Pageof 29